Disulfiram Attenuates Bleomycin-Induced Lung Inflammation and Fibrosis with Reduced Endothelial Pyroptosis and Neutrophil Adhesion
Chuan-Yen Sun, Wan-Ling Yang, Hsiao-Chin Shen, Wen-Kuang Yu, Wei-Chih Chen, Kuang-Yao Yang · 2026
Read Disulfiram Attenuates Bleomycin-Induced Lung Inflammation and Fibrosis with Reduced Endothelial Pyroptosis and Neutrophil Adhesion by Chuan-Yen Sun, Wan-Ling Yang, Hsiao-Chin Shen, Wen-Kuang Yu, Wei-Chih Chen, Kuang-Yao Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13225160.txt.
Description
Chuan-Yen Sun and colleagues test a 2026 repurposing idea in mice: disulfiram, a decades-old drug used against alcohol dependence, as a treatment for scarring lung disease. In the standard bleomycin injury model, white blood cells called neutrophils drive much of the damage, yet few therapies target them. Treated mice received daily injections starting a day after lung injury.
Tissue scoring showed clearly less inflammation and scarring in treated animals. Levels of a protein fragment central to pyroptosis, an inflammatory form of cell death, also fell in blood vessel lining cells. Markers of neutrophil presence and stickiness dropped as well, suggesting the drug calms both vessel injury and neutrophil recruitment in injured lungs.
Catalog record
| CREATOR | Chuan-Yen Sun, Wan-Ling Yang, Hsiao-Chin Shen, Wen-Kuang Yu, Wei-Chih Chen, Kuang-Yao Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |